{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:24:57Z","timestamp":1795094697928,"version":"4.10.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019711","name":"London Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijrobp.2024.06.033","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:13:35Z","timestamp":1720505615000},"page":"1231-1238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease"],"prefix":"10.1016","volume":"120","author":[{"given":"Timothy K.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4545-4968","authenticated-orcid":false,"given":"Sherif","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Corkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"O\u2019 Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Celinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Fakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirami","family":"Hallock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohann J.M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Melody","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pencilla","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Velker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-7360","authenticated-orcid":false,"given":"Glenn S.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.06.033_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0002","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.18632\/oncotarget.3455","article-title":"The biology and treatment of oligometastatic cancer","volume":"6","author":"Reyes","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0003","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clon.2020.06.018","article-title":"Stereotactic radiosurgery and stereotactic body radiotherapy in the management of oligometastatic disease","volume":"32","author":"Chen","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0004","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00345-019-02873-w","article-title":"Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer","volume":"37","author":"Patel","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fonc.2019.00337","article-title":"Stereotactic body radiotherapy (SBRT) for oligometastatic spine metastases: An overview","volume":"9","author":"Zeng","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0006","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): Study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): A multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0009","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1200\/JCO.2005.04.754","article-title":"Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression","volume":"23","author":"Rades","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0010","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1200\/JCO.2014.55.1143","article-title":"Role of radiation therapy in palliative care of the patient with cancer","volume":"32","author":"Lutz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2019.12.023","article-title":"Beyond oligometastases","volume":"107","author":"Palma","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0012","doi-asserted-by":"crossref","first-page":"100734","DOI":"10.1016\/j.adro.2021.100734","article-title":"Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial","volume":"6","author":"Corkum","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-021-08020-2","article-title":"Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy","volume":"21","author":"Bauman","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0014","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clon.2008.05.005","article-title":"Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: Report of a 10-year experience","volume":"20","author":"Bashir","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(96)00248-9","article-title":"Fractionated half-body irradiation for pain palliation in widely metastatic cancers: Comparison with single dose","volume":"36","author":"Salazar","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0016","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0017","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140712","article-title":"Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease","volume":"88","author":"Bhattacharya","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0018","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.rpor.2014.10.004","article-title":"Is stereotactic body radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?","volume":"20","author":"Jereczek-Fossa","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0019","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","article-title":"A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): A collaboration of MITO, AIRO GYN, and MaNGO Groups","volume":"25","author":"Macchia","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0020","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mdu370","article-title":"Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients","volume":"25","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13014-017-0820-1","article-title":"Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases","volume":"12","author":"Yeung","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0022","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ijrobp.2008.07.035","article-title":"Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions","volume":"73","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0023","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/cancers15030780","article-title":"Dosimetric impact of lesion number, size, and volume on mean brain dose with stereotactic radiosurgery for multiple brain metastases","volume":"15","author":"La Rosa","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195149","article-title":"Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis","volume":"13","author":"Hong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"General thoracic surgery long-term results of lung metastasectomy: Prognostic analysis based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0026","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214599","article-title":"Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer","volume":"14","author":"Shirasawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0028","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/cncr.31870","article-title":"Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study","volume":"125","author":"Barzilai","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0029","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-11-2217","article-title":"Survival of 1,181 patients in a phase I clinic: The MD Anderson Clinical Center for targeted therapy experience","volume":"18","author":"Wheler","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0030","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.bjc.6604218","article-title":"Clinical outcome and prognostic factors for patients treated within the context of a phase I study: The Royal Marsden Hospital experience","volume":"98","author":"Arkenau","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0031","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015276414526","article-title":"Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening","volume":"11","author":"Cella","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0033","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijrobp.2024.06.033_bib0034","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624025410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624025410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T23:27:50Z","timestamp":1731626870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624025410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0360301624025410"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}